-
1مورد إلكتروني
مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link -
2مورد إلكتروني
مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link -
3مورد إلكتروني
مصطلحات الفهرس: article, cell level, cell viability, enzyme activity, leishmaniasis, macrophage, male, mouse, priority journal, 6 aminonicotinamide, glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], lipopolysaccharide, melatonin, nitric oxide, nonhuman, alternative medicine, amastigote, animal cell, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35746
International Immunopharmacology
Click here for full text options
LibKey Link -
4مورد إلكتروني
مصطلحات الفهرس: transcription regulation, umbilical vein endothelial cell, upregulation, fructose bisphosphatase/ec [Endogenous Compound], heme oxygenase 1/ec [Endogenous Compound], hemin/ec [Endogenous Compound], hypoxia inducible factor 1alpha/ec [Endogenous Compound], multidrug resistance protein 1/ec [Endogenous Compound], organic anion transporter/ec [Endogenous Compound], phosphoinositide dependent protein kinase 1/ec [Endogenous Compound], prolyl hydroxylase inhibitor, pyruvate dehydrogenase kinase/ec [Endogenous Compound], pyruvate dehydrogenase kinase 2/ec [Endogenous Compound], pyruvate dehydrogenase kinase 4/ec [Endogenous Compound], quercetin/cm [Drug Comparison], quercetin/pd [Pharmacology], quercetin derivative/cm [Drug Comparison], transcription factor Nrf2/ec [Endogenous Compound], unclassified drug, 6 phosphofructo 2 kinase fructose 2,6 biphosphatase 3/ec [Endogenous Compound], dimethyloxalylglycine, organic anion transporter polypeptide 4C1/ec [Endogenous Compound], pyruvate dehydrogenase kinase 3/ec [Endogenous Compound], quercetin 3-O-glucuronide/cm [Drug Comparison], quercetin 3' o sulfate/cm [Drug Comparison], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], article, chronic drug administration, controlled study, down regulation, energy metabolism, genetic transcription, glucose metabolism, glucose transport, glycolysis, human, human cell, priority journal, protein expression, protein stability, signal transduction, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35692
Free Radical Biology and Medicine
Click here for full text options
LibKey Link -
5مورد إلكتروني
مصطلحات الفهرس: article, cell level, cell viability, enzyme activity, leishmaniasis, macrophage, male, mouse, priority journal, 6 aminonicotinamide, glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], lipopolysaccharide, melatonin, nitric oxide, nonhuman, alternative medicine, amastigote, animal cell, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35746
International Immunopharmacology
LibKey Link -
6مورد إلكتروني
مصطلحات الفهرس: transcription regulation, umbilical vein endothelial cell, upregulation, fructose bisphosphatase/ec [Endogenous Compound], heme oxygenase 1/ec [Endogenous Compound], hemin/ec [Endogenous Compound], hypoxia inducible factor 1alpha/ec [Endogenous Compound], multidrug resistance protein 1/ec [Endogenous Compound], organic anion transporter/ec [Endogenous Compound], phosphoinositide dependent protein kinase 1/ec [Endogenous Compound], prolyl hydroxylase inhibitor, pyruvate dehydrogenase kinase/ec [Endogenous Compound], pyruvate dehydrogenase kinase 2/ec [Endogenous Compound], pyruvate dehydrogenase kinase 4/ec [Endogenous Compound], quercetin/cm [Drug Comparison], quercetin/pd [Pharmacology], quercetin derivative/cm [Drug Comparison], transcription factor Nrf2/ec [Endogenous Compound], unclassified drug, 6 phosphofructo 2 kinase fructose 2,6 biphosphatase 3/ec [Endogenous Compound], dimethyloxalylglycine, organic anion transporter polypeptide 4C1/ec [Endogenous Compound], pyruvate dehydrogenase kinase 3/ec [Endogenous Compound], quercetin 3-O-glucuronide/cm [Drug Comparison], quercetin 3' o sulfate/cm [Drug Comparison], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], article, chronic drug administration, controlled study, down regulation, energy metabolism, genetic transcription, glucose metabolism, glucose transport, glycolysis, human, human cell, priority journal, protein expression, protein stability, signal transduction, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35692
Free Radical Biology and Medicine
LibKey Link